Seeking Alpha

EyePoint up 12% premarket on expanded access of Dexycu

|About: EyePoint Pharmaceuticals, ... (EYPT)|By:, SA News Editor

EyePoint Pharmaceuticals (NASDAQ:EYPT) has entered into a formal two-year contract with one of the largest integrated delivery systems in the U.S. to offer DEXYCU (dexamethasone intraocular suspension 9%) within its network.

This agreement opens up new distribution channels in California, Washington, Georgia, Colorado and mid-Atlantic states.

Shares are up 12% premarket.

Try Seeking Alpha PREMIUM for unlimited analysis on EYPT